医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

10x Genomics Accelerates Asia Pacific Expansion with Japanese Distributor Agreement

2016年09月15日 PM09:00
このエントリーをはてなブックマークに追加


 

PLEASANTON, Calif.

10x Genomics, Inc., a company focused on expanding genomics applications by providing researchers with access to critical longrange genomic information and gene expression at single cell-resolution, today announced that it has entered into a distribution agreement with SCRUM Inc. to bring the ChromiumTM System and associated products to the rapidly expanding Japanese market.

“With the addition of our new Japanese partner, 10x has successfully inked distribution arrangements throughout the Asia Pacific region, a growing market that is hungry for new and more powerful sequencing solutions,” said Serge Saxonov, Ph.D., co-founder and chief executive officer of 10x Genomics. “Having analyzed a number of exceptional partnering opportunities in the region, we are pleased to be working with SCRUM Inc. to deliver these new capabilities to our current and future customers in Japan.”

The company’s recently launched Chromium System is a microfluidics-based molecular barcoding system, built upon their proprietary GemCode™ Technology. The single instrumentation system can run multiple, powerful applications, including the Chromium Genome and Exome Solutions, which both provide novel long-range genomic data called “linked-reads.” The Chromium workflows utilize a customer’s existing short-read sequencer, and enable more expansive characterization of previously inaccessible genomic information. In addition, the Chromium Single Cell Solution allows for high-throughput, deep profiling of complex cell populations through single-cell gene expression analysis.

“The value of 10x Genomics’ platform has already been well validated by many genomic researchers and commercial research organizations,” said Takemitsu Furuta, executive director, business development of SCRUM. “We recently held a Chromium System seminar and received overwhelmingly positive feedback from potential users, which reiterates our confidence that this system has the ability to positively impact the efficiency and quality of our customers’ research.”

In May of this year, 10x announced key distribution agreements with MDxK, Inc., Millennium Science Pty Ltd, Research Instruments Pte Ltd and Star Research Technology Ltd., in South Korea, Australia and New Zealand, Southeast Asia and China respectively. More distributor information can be found at 10xGenomics.com/distributors.

About 10x Genomics

10x Genomics is changing the definition of sequencing by providing an innovative genomics platform that dramatically upgrades the capabilities of existing sequencing technologies. This is achieved through a combination of new microfluidic science, chemistry and bioinformatics. By implementing GemCodeTM Technology within the Chromium System, researchers can now, for the first time, find new structural variants, haplotypes, and other valuable genomic information with comprehensive workflows for Single Cell, Genome and Exome applications that incorporate their pre-existing sequencing technologies.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160915005750/en/

CONTACT

Pure Communications, Inc.
Media Contact:
Dan Budwick,
973-271-6085
dan@purecommunicationsinc.com
or
Investor
Contact:

Matt Clawson, 949-370-8500
matt@purecommunicationsinc.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in Esophageal Squamous Cell Cancer (ESCC) In China
  • AVEO Announces Acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) Trial in Esophageal Squamous Cell Cancer (ESCC) in China
  • STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic Cooperation Agreement
  • 新研究调查诊断性多通道睡眠检查之前采用Masimo SET®脉搏氧饱和度仪居家监测筛查唐氏综合征患儿罹患阻塞性睡眠呼吸暂停的风险
  • ダウン症候群の小児を対象とする睡眠時障害診断のマルチチャンネル研究に先立つ閉塞性睡眠時無呼吸症リスクのスクリーニングとしてMasimo SET®パルスオキシメトリーを使用するホームモニタリングの有用性を検討する新研究